-
Loading metrics
Cost-minimization analysis of subcutaneous versus intravenous trastuzumab administration in Chilean patients with HER2-positive early breast cancer
- Luis Rojas,
- Sabrina Muñiz,
- Lidia Medina,
- Jose Peña,
- Francisco Acevedo,
- Mauricio P. Pinto,
- Cesar Sanchez
x
- Published: February 5, 2020
- https://doi.org/10.1371/journal.pone.0227961